Form 4 for CALX CALIX, INC
Accepted 2025-07-24 00:00:00 ET · period of report 2025-07-22 · accession 0001678385-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-24 | 2025-07-22+ | CALX | Weening Michael | Pres, CEO, Dir | S - Sale+OE | $55.62 | -200.0K | 15.8K | -93% | -$11.12M |
| DM | 2025-07-24 | 2025-07-22+ | CALX | Weening Michael | Pres, CEO, Dir | M - OptEx | $6.12 | +200.0K | 31.8K | New | +$1.22M |
| DM | 2025-07-24 | 2025-07-22+ | CALX | Weening Michael | Pres, CEO, Dir | M - OptEx | $0.00 | -200.0K | 74.0K | -73% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-22 | S | D | 92,000 | $55.00 | 15,812 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-22 | M | A | 92,000 | $5.95 | 107,812 | D | — | — | |
| 3 | Common | Common Stock | 2025-07-23 | M | A | 92,000 | $5.95 | 107,812 | D | — | — | |
| 4 | Common | Common Stock | 2025-07-23 | S | D | 92,000 | $56.00 | 15,812 | D | — | — | |
| 5 | Common | Common Stock | 2025-07-23 | M | A | 16,000 | $8.03 | 31,812 | D | — | — | |
| 6 | Common | Common Stock | 2025-07-23 | S | D | 16,000 | $57.00 | 15,812 | D | — | — | |
| 7 | Derivative | Stock Option (right to buy) | 2025-07-23 | M | D | 92,000 | $0.00 | 0 | D | $5.95 · — to 2027-12-29 | 92,000 Common Stock | (F1) 100% of the shares subject to the option were fully vested and exercisable on January 1, 2021. |
| 8 | Derivative | Stock Option (right to buy) | 2025-07-22 | M | D | 92,000 | $0.00 | 92,000 | D | $5.95 · — to 2027-12-29 | 92,000 Common Stock | (F1) 100% of the shares subject to the option were fully vested and exercisable on January 1, 2021. |
| 9 | Derivative | Stock Option (right to buy) | 2025-07-23 | M | D | 16,000 | $0.00 | 74,000 | D | $8.03 · — to 2029-02-14 | 16,000 Common Stock | (F2) 100% of the shares subject to the option were fully vested and exercisable on February 14, 2023. |